Biotalys NV (BTLS) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.154x

Based on the latest financial reports, Biotalys NV (BTLS) has a cash flow conversion efficiency ratio of -0.154x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.05 Million ≈ $-3.56 Million USD) by net assets (€19.81 Million ≈ $23.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biotalys NV - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Biotalys NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Biotalys NV for a breakdown of total debt and financial obligations.

Biotalys NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotalys NV ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MICROPORT CARDIO.MEDTECH.
F:72X
N/A
LIG-ES SPAC
KQ:220260
0.025x
Samyang Tongsang Co. Ltd.
KO:002170
0.026x
W5 Solutions AB
ST:W5
0.082x
Loop Telecommunication International Inc
TW:3025
-0.014x
Hotron Precision Electronic Industrial Co Ltd
TW:3092
-0.048x
Donegal Group B Inc
NASDAQ:DGICB
0.016x
Uniquest
KO:077500
-0.059x

Annual Cash Flow Conversion Efficiency for Biotalys NV (2019–2024)

The table below shows the annual cash flow conversion efficiency of Biotalys NV from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Biotalys NV stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €27.61 Million
≈ $32.27 Million
€-12.65 Million
≈ $-14.79 Million
-0.458x +35.91%
2023-12-31 €25.57 Million
≈ $29.89 Million
€-18.28 Million
≈ $-21.37 Million
-0.715x -35.65%
2022-12-31 €38.11 Million
≈ $44.56 Million
€-20.09 Million
≈ $-23.49 Million
-0.527x -85.36%
2021-12-31 €58.91 Million
≈ $68.88 Million
€-16.75 Million
≈ $-19.59 Million
-0.284x +23.49%
2020-12-31 €25.65 Million
≈ $29.99 Million
€-9.53 Million
≈ $-11.15 Million
-0.372x +4.76%
2019-12-31 €21.07 Million
≈ $24.64 Million
€-8.22 Million
≈ $-9.61 Million
-0.390x --

About Biotalys NV

BR:BTLS Belgium Agricultural Inputs
Market Cap
$131.77 Million
€112.71 Million EUR
Market Cap Rank
#18904 Global
#86 in Belgium
Share Price
€3.00
Change (1 day)
+1.87%
52-Week Range
€1.66 - €5.28
All Time High
€7.76
About

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6… Read more